FDA Says Ketamine Hydrochloride Injection Shortage Resolved As Of April 2 - Website
April 2 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
Source text: [ID:]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.